Par Drugs & Chemicals Ltd.
PAR
Par Drugs & Chemicals Ltd.
PAR
Par Drugs & Chemicals Ltd. Share Price
100.21 +0.65 (+0.65%)Fundamentals
Market Cap₹122Cr | EPS₹10.65 |
Book Value/Share₹94.84 | P/E Ratio (TTM)11.96 |
Industry P/E (TTM)45.66 | P/B Ratio1.17 |
Long Term D/E0.00 | ROE14.47% |
Dividend Yield (TTM)0.00% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Underperformer
Excellent Quality
Low Price Fluctuation
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Par Drugs & Chemicals Ltd.
The share price of Par Drugs & Chemicals Ltd. is ₹100.21 on NSE as of 28/8/2026, 6:27:58 pm. Share prices may change frequently due to market movements.
The market capitalisation of Par Drugs & Chemicals Ltd. is ₹122Cr as of 28/8/2026, 6:27:58 pm
The current Price to Earnings (P/E) ratio of Par Drugs & Chemicals Ltd. is 11.97 as of 28/8/2026, 6:27:58 pm
The Price to Book (P/B) ratio of Par Drugs & Chemicals Ltd. stands at 1.17 as of 28/8/2026, 6:27:58 pm
Par Drugs & Chemicals Ltd. reported an ROE of 14.47% for the last reported financial year on a consolidated account basis.
As of 28/8/2026, 6:27:58 pm, Par Drugs & Chemicals Ltd.’s shareholding pattern is: promoters hold 73.40%, FIIs hold 0.00%, DIIs hold 0.10%, and public shareholders hold 26.50%.
The 52-week high of Par Drugs & Chemicals Ltd. is ₹100.90 and the 52-week low is ₹99.00 as of 28/8/2026, 6:27:58 pm.
The earnings per share (EPS) of Par Drugs & Chemicals Ltd. is ₹3.83 for the quarter ended Jun 2026.
The stock symbol of Par Drugs & Chemicals Ltd. is PAR.
You can buy Par Drugs & Chemicals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Par Drugs & Chemicals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Jun 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 31.28 | +59.51% |
| Other Income | 0.94 | +161.11% |
| Total Income | 32.22 | +61.34% |
| Total Expenditure | 24.90 | +37.04% |
| EBIDT | 7.32 | +306.67% |
| Depreciation | 0.96 | +3.23% |
| Interest | 0.02 | -50.00% |
| Tax | 1.62 | -8,200.00% |
| Net Profit | 4.71 | +454.12% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 64.33 |
| Total Non-Current Assets | 64.89 |
| Fixed assets | 37.16 |
| Total Assets | 129.21 |
| Total Current liabilities | 13.74 |
| Total Non Current Liabilities | 3.48 |
| Total Equity Plus Liabilities | 129.21 |
| Total Shareholder Funds | 111.98 |
| Total Debt to Equity | 0.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 16.43 |
| Cash from Financing Activities | 0.00 |
| Cash from Investing Activities | -2.17 |
| Net Cash Flow | 14.27 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages7
Bearish Moving Averages9
5 Day
100.5010 Day
101.0020 Day
100.6030 Day
99.8050 Day
96.70100 Day
93.50150 Day
92.70200 Day
93.70Indicators
RSI (14)
50.48MACD (12, 26)
1.06MACD Signal Line (9)
1.51MFI (14)
52.51ATR (14)
4.62ADX (14)
28.05ROC (21)
3.88ROC (125)
2.50Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 99.98 | 100.40 | 100.81 | 99.57 | 99.15 | 98.74 | 98.32 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Jun 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 31.28 | +59.51% |
| Other Income | 0.94 | +161.11% |
| Total Income | 32.22 | +61.34% |
| Total Expenditure | 24.90 | +37.04% |
| EBIDT | 7.32 | +306.67% |
| Depreciation | 0.96 | +3.23% |
| Interest | 0.02 | -50.00% |
| Tax | 1.62 | -8,200.00% |
| Net Profit | 4.71 | +454.12% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 64.33 |
| Total Non-Current Assets | 64.89 |
| Fixed assets | 37.16 |
| Total Assets | 129.21 |
| Total Current liabilities | 13.74 |
| Total Non Current Liabilities | 3.48 |
| Total Equity Plus Liabilities | 129.21 |
| Total Shareholder Funds | 111.98 |
| Total Debt to Equity | 0.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 16.43 |
| Cash from Financing Activities | 0.00 |
| Cash from Investing Activities | -2.17 |
| Net Cash Flow | 14.27 |
Par Drugs & Chemicals Ltd.
PAR
Open Price | 99.00 |
Prev Close | 99.56 |
Upper Circuit | 119.47 |
Lower Circuit | 79.65 |
Volume | 3,407 |
Average Traded Price | 99.36 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |